123707

Infant botulism often stems from environmental spores found in soil or honey. For parents, the sudden onset of "floppy baby syndrome" is a nightmare. The unit established by Section 123707 acts as a global safeguard, ensuring that the specialized antibodies needed to neutralize botulinum toxins are always available, tested, and ready for the infants who need them most.

The Sentinel of the Cradle: Inside California’s Lifesaving Botulism Unit

In the quiet labs of the California Department of Public Health, a specialized team works under a unique legal mandate to solve a terrifying medical mystery: infant botulism. While rare, this condition can paralyze an infant’s muscles, making it impossible for them to breathe or eat. 123707

: Because cases of infant botulism can fluctuate by up to 60% annually , any unspent funds at the end of a fiscal year are automatically carried forward. This "rainy day" provision ensures that when an outbreak occurs, the resources are already in place.

Below is a feature article written about this unit and its critical mission. Infant botulism often stems from environmental spores found

The number refers to California Health and Safety Code § 123707 , which governs the Infant Botulism Treatment and Prevention Unit . This unit is responsible for the manufacture, distribution, and licensure of Botulism Immune Globulin Intravenous (Human) , a life-saving treatment for infants.

AI responses may include mistakes. For legal advice, consult a professional. Learn more California Code, Health and Safety Code - HSC § 123707 The Sentinel of the Cradle: Inside California’s Lifesaving

Governed by California Health and Safety Code § 123707 , the Infant Botulism Treatment and Prevention Unit isn't just a regulatory body—it’s a manufacturer. It is the primary entity authorized to handle the distribution and licensure of Botulism Immune Globulin Intravenous (Human) , often referred to by its trade name, BabyBIG®.